Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05006833 · ClinicalTrials.gov registry record · NA
Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness
A NA study of Hpv, sponsored by University of Florida.
- Active
- Registry status
- NA
- Development phase
- 21,110
- Enrollment target
- 1
- Study location
NCT05006833: Active NA study of Hpv, sponsored by University of Florida.
NCT05006833 is a NA study of Hpv that is active but no longer recruiting, run by University of Florida. The registered enrollment target is 21,110 participants, above the 1,362-participant average among 24 other Hpv trials with a reported enrollment target (1450% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05006833, a NA study of Hpv, is active but no longer recruiting, sponsored by University of Florida.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 21,110 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the effectiveness of two interventions (parent-targeted text messages and a brief clinician-targeted training) at increasing HPV vaccination among 11- to 12-year-olds living in Florida.
Primary Outcome
Binary measure at the participant level of receipt of one or more does of the HPV vaccine. The percentage of participants is estimated with predicted probabilities to adjust for clustering at the clinic-level.
Conditions Studied
Interventions
- BEHAVIORAL Brief Provider Training - Bundled Approach
- BEHAVIORAL Brief Provider Training - Benefits Approach
- BEHAVIORAL Parent Interactive Text Message - Bundled Approach
- BEHAVIORAL Parent Interactive Text Message - Benefits Approach
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21,110 participants |
| Start Date | 2021-11-18 |
| Est. Completion | 2026-03-30 |
| Phase | NA |
What the registry record for NCT05006833 still lists
NCT05006833 is an interventional study that assigns participants to a tested intervention. Its 21,110 participants enrollment target places it among the larger protocols in the corpus, above the 1,362-participant average among 24 other Hpv trials with a reported enrollment target (1450% higher).
The record links to 1 condition, with Hpv appearing as the primary indexed condition, and to 4 interventions - of which Brief Provider Training - Bundled Approach is the first listed.
NCT05006833 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05006833 about?
NCT05006833 is a clinical study titled "Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness". This study will test the effectiveness of two interventions (parent-targeted text messages and a brief clinician-targeted training) at increasing HPV vaccination among 11- to 12-year-olds living in Florida.
What is the current status of trial NCT05006833?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 21,110 participants. The study started on 2021-11-18. Estimated completion is 2026-03-30.
What conditions does trial NCT05006833 study?
This clinical trial studies the following conditions: Hpv.
What interventions are being tested in trial NCT05006833?
The interventions under investigation include: Brief Provider Training - Bundled Approach (BEHAVIORAL), Brief Provider Training - Benefits Approach (BEHAVIORAL), Parent Interactive Text Message - Bundled Approach (BEHAVIORAL), Parent Interactive Text Message - Benefits Approach (BEHAVIORAL).
Who is sponsoring clinical trial NCT05006833?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05006833 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hpv
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05006833's enrollment target sits among peer trials
21,110 1st of 24 higher than 24 of 24 other Hpv trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hpv trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination
RECRUITING · NA
-
HPV Self-Collection Program
RECRUITING · NA
-
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
RECRUITING · NA
-
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening
RECRUITING · NA
-
Playing Game to Learn About Children's Vaccine Project
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07213531 · 21,000 participants
Enhanced Valves Interventions and Safe AI Generated End Results
- NCT06047041 · 21,350 participants · NA
Implementation Supports for Improving Identification and Delivery of School-based Mental Health Supports for Middle Schools Students
- NCT06062342 · 20,400 participants · NA
Five Point Initiative: A Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities
- NCT05832307 · 22,000 participants · NA
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI